Regulatory T-cell subsets and their roles in transplantation tolerance

Current Opinion in Organ Transplantation

Volumn 11, Issue 4, 2006, Pages 373-378

  Chen, Wenhao ^a,b   Zhang, Li ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Regulation; T cell; Tolerance; Transplantation

Indexed keywords

CHEMOKINE RECEPTOR CXCR5; COMPLEMENTARY DNA; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLOGRAFT; ANTIGEN SPECIFICITY; CD4+ CD25+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURFACE; DENDRITIC CELL; DNA MICROARRAY; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; HEART GRAFT; HUMAN; IMMUNE RESPONSE; LITERATURE; LYMPH NODE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; REGULATORY T LYMPHOCYTE; REVIEW; SKIN TRANSPLANTATION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; THYMECTOMY; THYMUS; TRANSPLANTATION TOLERANCE; XENOGRAFT;

EID: 33746347339     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/01.mot.0000236699.52834.6f     Document Type: Review

References (64)

1. Lechler RI, Sykes M, Thomson AW, Turka LA. Organ transplantation: how much of the promise has been realized? Nat Med 2005; 11:605-613. An excellent review that demonstrates the major challenges, progress, and optimism in the organ transplantation field.
2. Graca L, Chen TC, Le Moine A, et al. Dominant tolerance: activation thresholds for peripheral generation of regulatory T cells. Trends Immunol 2005; 26:130-135.
3. Walsh PT, Taylor DK, Turka LA. Tregs and transplantation tolerance. J Clin Invest 2004; 114:1398-1403.
4. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22:531-562.
5. + regulatory T cells: mechanisms of induction and effector function. Autoimmun Rev 2005; 4:491-496.
6. Suciu-Foca N, Manavalan JS, Scotto L, et al. Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review. Int Immunopharmacol 2005; 5:7-11.
7. Oh K, Kim S, Park SH, et al. Direct regulatory role of NKT cells in allogeneic graft survival is dependent on the quantitative strength of antigenicity. J Immunol 2005; 174:2030-2036.
8. Zhang ZX, Yang L, Young KJ, et al. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med 2000; 6:782-789.
9. Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol 2006; 24:209-226.
10. + Treg thymic generation on CD28 costimulation.
11. + Treg generation in human thymus.
12. - cells and isolated by HLA class II tetramers.
13. + Tregs versus those that help the proliferation of established Tregs.
14. + regulatory T cells by TGF-beta induction of transcription factors Foxp3. J Exp Med 2003; 198:1875-1886.
15. + precursors in a thymus-independent process. J Immunol 2004; 172:923-928.
16. + Tregs.
17. + Tregs.
18. + Tregs can inhibit allogeneic responses in an antigen-nonspecific manner.
19. Quezada SA, Bennett K, Blazar BR, et al. Analysis of the underlying cellular mechanisms of anti-GD154-induced graft tolerance: the interplay of clonal anergy and immune regulation. J Immunol 2005; 175:771-779. This report indicates the independent contribution of anergy and Treg-mediated suppression to the fate of alloreactive T cells in vivo.
20. + Treg homing to allografts is CCR4 dependent, and that trafficking of Tregs to allograft is required for maintenance of allograft tolerance.
21. + T cells via a CD30-dependent mechanism. J Clin Invest 2004; 113:310-317.
22. + Tregs require activation through their TCR to suppress allogeneic responses.
23. high Tregs homing to lymph nodes are required for transplant tolerance induction.
24. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195:1641-1646.
25. + Tregs prevent initial activation of T cells and their differentiation into effector cells within lymph nodes.
26. Shen S, Ding Y, Tadokoro CE, et al. Control of homeostatic proliferation by regulatory T cells. J Clin Invest 2005; 115:3517-3526.
27. Grossman WJ, Verbsky JW, Barchet W, et al. Human T regulatory cells can use the perform pathway to cause autologous target cell death. Immunity 2004; 21:589-601.
28. + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 2005; 174:1783-1786.
29. + T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. Blood 2005; 105:2845-2851.
30. Workman CJ, Vignali DA. Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223). J Immunol 2005; 174:688-695.
31. Caramalho I, Lopes-Carvalho T, Ostler D, et al. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003; 197:403-411.
32. + Tregs can reverse their function.
33. Beyersdorf N, Gaupp S, Balbach K, et al. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. J Exp Med 2005; 202:445-455.
34. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 2005; 201:723-735.
35. + Tregs remains TGF-β dependent.
36. + Tregs remains TGF-β dependent.
37. + Treg suppressor function is IL-10 dependent, but IL-10 production by Tregs themselves is not required for suppression.
38. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med 2002; 196:237-246.
39. + regulatory T cells suppress effector T cell proliferation. Clin Immunol 2005; 115:3-9.
40. + immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells. J Immunol 2006; 176:1266-1273.
41. - T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance. Transplantation 2005; 79:1310-1316. Adoptive transfer of Foxp3-transduced T cells has been shown to prevent allograft rejection, suggesting the therapeutic potential of Tregs.
42. Vlad G, Cortesini R, Suciu-Foca N. License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC. J Immunol 2005; 174:5907-5914.
43. Gonzalez-Rey E, Chorny A, Fernandez-Martin A, et al. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells. Blood 2006; 107:3632-3638.
44. + regulatory T cells by inhibition of APC proteosome function. J Immunol 2005; 174:2787-2795.
45. + T-regulatory cells. Transplantation 2005; 79:1056-1061. This paper demonstrates that pretransplant infusion of in vitro-generated donor-derived tolerogenic dendritic cells prolongs allograft survival.
46. Gregori S, Casorati M, Amuchastegui S, et al. Regulatory T cells induced by 1 α,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001; 167:1945-1953.
47. + Treg subsets.
48. + T cells to rapamycin induces expansion of Tregs.
49. Priatel JJ, Utting O, Teh HS. TCR/self-antigen interactions drive double-negative T cell peripheral expansion and differentiation into suppressor cells. J Immunol 2001; 167:6188-6194.
50. Young KJ, DuTemple B, Phillips MJ, Zhang L. Inhibition of graft-versus-host disease by double-negative regulatory T cells. J Immunol 2003; 171:134-141.
51. Young KJ, Kay LS, Phillips MJ, Zhang L. Antitumor activity mediated by double-negative T cells. Cancer Res 2003; 63:8014-8021.
52. Wang R, Wang-Zhu Y, Grey H. Interactions between double positive thymocytes and high affinity ligands presented by cortical epithelial cells generate double negative thymocytes with T cell regulatory activity. Proc Natl Acad Sci U S A 2002; 99:2181-2186.
53. - double-negative regulatory T cells. Blood 2005; 105:2828-2835. This study demonstrates that double-negative Treg cells exist in humans that are able to suppress antigen-specific T cells.
54. Chen W, Ford MS, Young KJ, Zhang L. Infusion of in vitro-generated DN T regulatory cells induces permanent cardiac allograft survival in mice. Transplant Proc 2003; 35:2479-2480.
55. Young KJ, Yang LM, Phillips MJ, Zhang L. Donor-lymphocyte infusion induces tolerance by activating systemic and graft-infiltrating double negative T regulatory cells. Blood 2002; 100:3408-3414.
56. Chen WH, Ford M, Young KJ, et al. Role of double-negative regulatory T cells in long-term cardiac xenograft survival. J Immunol 2003; 170:1846-1853.
57. +T cell-mediated xenograft rejection.
58. Ford MS, Young KJ, Zhang ZX, et al. The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. J Exp Med 2002; 196:261-267.
59. Lee BP, Mansfield E, Hsieh SC, et al. Expression profiling of murine double-negative regulatory T cells suggest mechanisms for prolonged cardiac allograft survival. J Immunol 2005; 174:4535-4544. Global gene expression difference between functional double-negative Treg clones and their nonfunctional mutants was compared using cDNA microarray.
60. Lee BP, Chen W, Shi H, et al. CXCR5/CXCL13 interaction is important for double negative regulatory T cell homing to cardiac allografts. J Immunol 2006; 176:5276-5283. This paper studies the mechanism leading to the migration and accumulation of double-negative Tregs into tolerant allografts.
61. Battaglia M, Stabilini A, Draghici E, et al. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes 2006; 55:40-49.
62. Asiedu CK, Goodwin KJ, Balgansuren G, et al. Elevated T regulatory cells in long-term stable transplant tolerance in rhesus macaques induced by anti-CD3 immunotoxin and deoxyspergualin. J Immunol 2005; 175:8060-8068.
63. Beilke JN, Kuhl NR, Van Kaer L, Gill RG. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med 2005; 11:1059-1065.
64. Toyofuku A, Yasunami Y, Nabeyama K, et al. Natural killer T-cells participate in rejection of islet allografts in the liver of mice. Diabetes 2006; 55:34-39.